German Recommendations on Health Economic Evaluation: Third and Updated Version of the Hanover Consensus
J.-Matthias Graf von der Schulenburg(Leibniz University Hannover), Christian Weber(Munich Cluster for Systems Neurology), T Volmer, Herbert Rebscher(DAK-Gesundheit (Germany)), Oliver Schoeffski(Friedrich-Alexander-Universität Erlangen-Nürnberg), F Jost(Roche (Switzerland)), Reiner Leidl(Institute of Groundwater Ecology), Thomas Mittendorf(Leibniz University of Applied Sciences), Norbert Klusen(Techniker Krankenkasse (Germany)), Christoph Vauth(Leibniz University of Applied Sciences), S. Wahler(Verband Forschender Arzneimittelhersteller), Maria Kubin(Bayer (Germany)), Wolfgang Greiner(Bielefeld University)
Cited by 173
Related Papers
Barriers and Strategies in Guideline Implementation—A Scoping Review
|Healthcare|2016|946
Development of the EQ-5D-Y: a child-friendly version of the EQ-5D
|Quality of Life Research|2010|903
Microparticles
|Circulation Research|2010|769
German Value Set for the EQ-5D-5L
|PharmacoEconomics|2018|618
Feasibility, reliability, and validity of the EQ-5D-Y: results from a multinational study
|Quality of Life Research|2010|476